News & Updation
Best Paper Awards
World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.
Best Article of current issue
Download Article : Click here
THE PROPORTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION AMONG THE PEDIATRIC POPULATION IN THE STATE OF TRIPURA, NORTH EAST INDIA.
Apurba Sarkar, Saikat Majumder, Banti Das, Dr. Gourab Chakraborty and *Dr. Tapan Majumdar
Introduction: COVID-19 is a global crisis caused by SARS-COV-2. The virus was first reported in Wuhan, Hubei province, China; in December 2019. The incubation period of the virus is 2 to 14 days, average around 6.5 days in children and 5.4 days in adults. Asymptomatic infections are common in children. Method: ICMR recognized Viral Research & Diagnostic Laboratory of Agartala Government Medical College for conducting RT-PCR test for screening and confirmation of SARS-COV-2. Subsequently, tests were undertaken from 5th March 2020. All the tests were performed as per the testing strategies of ICMR on Strategy for COVID-19 testing in India. Extraction of viral RNA was done as per the manufacturer protocol of QIAGEN for QIAamp Viral RNA Mini Kit. The screening was done by targeting the SARS-CoV-2-specific ‘E gene’. Then the Confirmation was carried out by targeting the ‘RdRp gene’ and ‘ORF-1b’. Result: During this study period out of 100995 samples tested 6571 (7%) were children. 98% (6447) were negative and 2% (124) were positive for SARS-COV-2 by RT-PCR. In positive children, 62% (n=77) was male and 38% (n=47) was female. The most affected age group was 6 to 10 years (33%). The median age was 8 (0-14) years. 81% (n=101) was asymptomatic and 19% (n=23) was symptomatic. Symptoms were similar as Influenza like Symptoms. Conclusion: This study shows that 2% of the tested children were positive for SARS-COV-2, majority of them had positive household contact. 81% were asymptomatic and 19% had moderate symptoms without any mortality. COVID-19 is going to be added as another viral agent of the respiratory panel for future diagnosis and research.[Full Text Article]